Synthesis, characterization and antimicrobial activity evaluation of new imidazo [2,1-b][1,3,4]thiadiazole derivatives

Shankar Gaddeppa Alegaon, Kallanagouda Ramappa Alagawadi

Abstract


Imidazo[2,1-b][1,3,4]thiadiazoles (4a-g) were synthesized from 3,4,5-trimethoxy benzoic acid and thiosemicarbazide. Reaction of 4 with Vilsmeier-Haack reagent yielded imidazo [2,1-b][1,3,4] thiadiazole–5-carbaldehyde derivatives (5a-g). Obtained imidazo[2,1-b][1,3,4] thiadia zoles-5-carbaldehydes were subjected to Knoevenagel condensation with 2-(2,4-dioxothia zolidin-3-yl)acetic acid (1) and 2-(4-oxo-2-thioxothiazolidin-3-yl)acetic (2) in the presence of catalytic amount of piperidine and acetic acid to afford imidazo[2,1-b][1,3,4]thiadiazoles (6a-g) and (7a-g), respectively. The structures of the newly synthesized compounds were confirmed by IR, NMR and elemental analyses. All compounds were screened for their antibacterial and antifungal activities. Some of the compounds displayed good antibacterial and antifungal activity.

2_1_94_99_800


Keyword(s)


Thiazolidinedione; Thiadiazole; Imidazo[2,1-b][1,3,4]thiadiazoles; Antibacterial activity; Antifungal activity; Rhodanine

European Journal of Chemistry, 2 (1), (2011), 94-99

Full Text:

PDF    /    /

DOI: http://dx.doi.org/10.5155/eurjchem.2.1.94-99.161


References

[1]. Tenover, F. C.; McDonald, L. C. Curr. Opin. Infect. Dis. 2005, 18, 300-305.
doi:10.1097/01.qco.0000171923.62699.0c
PMid:15985825

[2]. Pfeltz, R. F.; Wilkinson, B. J. Curr. Drug. Targets Infect. Disord. 2004, 4, 273-294.
doi:10.2174/1568005043340470
PMid:15578969

[3]. Roberts, M. C. Curr. Drug. Targets Infect. Disord. 2004, 4, 207-215.
doi:10.2174/1568005043340678
PMid:15379732

[4]. Dessen, A.; Di Guilmi, A. M.; Vernet, T.; Dideberg, O. Curr. Drug. Targets Infect. Disord. 2001, 1, 63-77.
doi:10.2174/1568005013343272
PMid:12455234

[5]. Muroi, H.; Nihei, K.; Tsujimoto, K, and Kubo, I. Bioorg. Med. Chem. 2004, 12, 583-587.
doi:10.1016/j.bmc.2003.10.046

[6]. Chopra, I.; Schofield, C.; Everett, M.; O’Neill, K.; Miller, K.; Wilcox, M. Lancet Infect, Dis. 2008, 8, 133-139.
doi:10.1016/S1473-3099(08)70018-5

[7]. Terzioglu, N.; Gursoy, A. Eur. J. Med. Chem. 2003, 38, 781-786.
doi:10.1016/S0223-5234(03)00138-7

[8]. Kolavi, G.; Hegde, V.; Khazi, I M.; Gadad, P. Bioorg. Med. Chem. 2006, 14, 3069-3080.
doi:10.1016/j.bmc.2005.12.020

[9]. Gadad, A. K.; Mahajanshetti, C. S.; Nimbalkar, S.; Raichurkar, A. Eur. J. Med. Chem. 2000, 35, 853-857.
doi:10.1016/S0223-5234(00)00166-5

[10]. Andotra, C. S.; Langer, T. C.; Kotha, A. J. Indian Chem Soc. 1997, 72, 125-127.

[11]. Kumar, P. Chinese J. Chem. 2010, 28, 250-254.
doi:10.1002/cjoc.201090061

[12]. Andreani, A.; Bonazzi, D.; Rambaldi, M.; Fabbri, G.; Rainsford, K. D. Eur. J. Med. Chem. 1982, 17, 271-274.

[13]. Bhovi, V. K.; Bodke, Y. D. Current Chem. Biol. 2010, 4, 145-150.

[14]. Khazi, I. A. M.; Mahajanshetti, C. S.; Gadad, A. K.; Tarnalli, A. D.; Sultanpur, C. M. Arzneimittelforschung. 1996, 46, 949-952.
PMid:8931885

[15]. Andreani, A.; Leonia, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Simon, W. A.; Senn-Bilfinger, J. Arzneimittelforschung. 2000, 50, 550-553.
PMid:10918949

[16]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Bossa, R.; Galatulas, I. Eur. J. Med. Chem. 1986, 21, 451-453.

[17]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Rugarli, P. Eur. J. Med. Chem. 1987, 22, 19-22.
doi:10.1016/0223-5234(87)90169-3

[18]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Andreani, F. Collect. Czech. Chem. Commun. 1991, 56, 2436-2447.
doi:10.1135/cccc19912436

[19]. Terashima, H.; Hama, K.; Yamamoto, R.; Tsuboshima, M.; Kikkawa, I. and Shigata, Y. J. Pharmacol. Exp. Ther. 1984, 229, 226-230.

[20]. Yoshioka, T.; Fujita, T.; Kanai, T.; Aizawa,Y.; Kurumada, T.; Hasegawa, K.; Horikoshi, H. J. Med. Chem. 1989, 32, 421-428.
doi:10.1021/jm00122a022
PMid:2913302

[21]. Ayhan-Kilcigil, G.; Altanlar, N. Arzneimittelforschung. 2000, 50, 154-157.
PMid:10719619

[22]. Heerding, D. A.; Christmann, L. T.; Clark, T. J.; Holmes, D. J.; Rittenhouse, S. F.; Takata, D. T.; Venslavsky, J. W. Med. Chem. Lett. 2003, 13, 3771-3773.
doi:10.1016/j.bmcl.2003.07.010

[23]. Tuncbilek, M.; Altanlar N. Arch. Pharm. Chem. Life Sci. 2006, 339, 213-216.
doi:10.1002/ardp.200500180
PMid:16572478

[24]. Bozdag-Dundar, O.; Ozgen, O.; Mentese, A.; Altanlar, N.; Atli, O.; Kendi, E.; Ertan, R. Bioorg. Med. Chem. 2007, 15, 6012- 6017.
doi:10.1016/j.bmc.2007.06.049

[25]. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. J. Med. Chem. 1994, 37, 3977-3985.
doi:10.1021/jm00049a017
PMid:7966158

[26]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Leoin, A.; Bossa, R.; Chiericozzi, M.; Galatulas, I.; Salvatore, G. Eur. J. Med. Chem. 1993, 28, 825-829.
doi:10.1016/0223-5234(93)90118-X

[27]. De Lima, J. G.; Perrissin, M.; Chantegrel, J. Arzneimittelforschung. 1994, 44, 831-834.
PMid:7945517

[28]. Boschelli, D. H.; Connor, D. T.; Kuipers, P. J.; Wright, C. D. Bioorg. Med. Chem. Lett. 1992, 2, 705-708.
doi:10.1016/S0960-894X(00)80396-0

[29]. Al-Omar, M.; Al-Deeb, A.; Al-Khamees.; El-Emam, A. A. Phosphorus, Sulfur, and Silicon. 2004, 179, 2509-2517.
doi:10.1080/10426500490485525

[30]. Mazzone, G.; Bonina, F.; Puglisi, G.; Arrigo, R. R.; Cosentino, C.; Blandino, G. Farmaco Sci. 1982, 37, 685-700.
PMid:6982830

[31]. Maccari, R.; Ottana, R.; Curinga, C.; Vigorita, M. G.; Rakowitz, D.; Steindl, T.; Langer, T. Bioorg. Med. Chem. 2005, 13, 2809-2823.
doi:10.1016/j.bmc.2005.02.026

[32]. CLSI/NCCLS Guidelines: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; 7th Ed. Approved Standard document M-7:A5, Villanova, PA, NCCLS, 2006.


Refbacks

  • There are currently no refbacks.